LONDON, Nov. 7 - Inpharmatica and Celera Genomics said Wednesday that they had agreed to jointly develop a new database that would offer structural information about the human and mouse proteins contained in the Celera Discovery System.

Under the terms of the deal, Inpharmatica, which currently markets protein structure data through its Biopendium database, said it would use its bioinformatics tools to generate structural information from the human and mouse sequences Celera has decoded.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.